Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: anticoagulant activity and mechanism of action

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 156, Issue 3, 2010, Pages 206-215

  Mansour, Mohamed Ben ^a   Dhahri, Manel ^a   Hassine, Mohsen ^d   Ajzenberg, Nadine ^b,c   Venisse, Laurence ^b,c   Ollivier, Véronique ^b,c   Chaubet, Frédéric ^b,c   Jandrot Perrus, Martine ^b,c   Maaroufi, Raoui M ^e  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b INSERM   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^e UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Anticoagulant activity; Dermatan sulfate; Heparin cofactor II; Ray skin; Thrombin generation

Indexed keywords

BLOOD CLOTTING FACTOR 10A; DERMATAN SULFATE; HEPARIN; HEPARIN COFACTOR II; PROTHROMBIN A;

ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BIOASSAY; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG MECHANISM; HUMAN; IN VITRO STUDY; INHIBITION KINETICS; INTESTINE MUCOSA; MARINE SPECIES; MOLECULAR WEIGHT; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RAJA MONTAGUI; SWINE; THROMBIN TIME; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION;

RAJA MONTAGUI;

EID: 77952891387     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpb.2010.03.010     Document Type: Article

References (46)

1. Ben Mansour M., Dhahri M., Bertholon I., Ollivier V., Bataille I., Ajzenberg N., Hassine M., Jandrot-Perrus M., Chaubet F., Maaroufi R.M. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula). Thromb. Res. 2009, 123:887-894.
2. Ben Mansour M., Majdoub H., Bataille I., Roudesli M.S., Hassine M., Ajzenberg N., Chaubet F., Maaroufi R.M. Polysaccharides from the skin of ray Raja radula. Partial characterization and anticoagulant activity. Thromb. Res. 2009, 123:671-678.
3. Ben Mansour M., Dhahri M., Vénisse L., Jandrot-Perrus M., Chaubet F., Maaroufi R.M. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate. Thromb. Res. 2009, 123:902-908.
4. Bezeaud A., Denninger M.H., Guillin M.C. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur. J. Biochem. 1985, 153:491-496.
5. Bitter T., Muir H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 1962, 4:330-334.
6. Camacho N.P., West P., Torzilli P.A., Mendelsohn R. FTIR microscopic imaging of collagen and proteoglycan in bovine cartilage. Biopolymers. 2001, 62:1-8.
7. Cesaretti M., Luppi E., Maccari F., Volpi N. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site. Glycobiol. 2004, 14:1275-1284.
8. Chatziioannidis C.C., Karamanos N.K., Anagnostides S.T., Tsegenidis T. Purification and characterisation of a minor low-sulphated dermatan sulphate-proteoglycan from ray skin. Biochimie. 1999, 81:187-196.
9. Chatziioannidis C.C., Karamanos N.K., Tsegenidis T. Isolation and characterization of small dermatan sulphate proteoglycan from ray skin: Raja clavata. Comp. Biochem. Physiol. B. 1999, 124:15-24.
10. Choay J., Petitou M., Lormeau J.C., Sinäy P., Casu B., Gatti G. Structure-activity relationships in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem. Biophys. Res. Comm. 1983, 116:492-499.
11. Dellias J.M.M., Onofre G.R., Werneck C.C., Landeira-Fernandez A.N., Melo F.R., Farias W.R.L., Silva L.C.F. Structural composition and differential anticoagulant activities of dermatan sulfates from the skin of four species of rays, Dasyatis Americana, Dasyatis guttata, Aetobatus narinari and Potamotrygon motoro. Biochimie. 2004, 86:677-683.
12. Dodgson K.S., Price R.G. A note on the determination of the ester sulphate content of sulfated polysaccharides. Biochem. J. 1962, 84:106-110.
13. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination for sugars and related substances. Anal. Chem. 1956, 28:350-356.
14. Garnjanagoonchorn W., Wongekalak L., Engkagul A. Determination of chondroitin sulfate from different sources of cartilage. Chem. Eng. Process. 2006, 46:465-471.
15. Heinegard D., Sommarin Y. Isolation and characterization of proteoglycans. Methods Enzymol. 1987, 144:319-372.
16. Hemker H.C., Giesen P., Al Dieri R., Regnault V., De Smedt E., Wagenvoord R., et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol. Haemost. Thromb. 2003, 33:4-15.
17. Jandrot-Perrus M., Didry D., Guillin M.C., Nurden A.T. Cross-linking of alpha and gamma-thrombin to distinct binding sites on human platelets. Eur. J. Biochem. 1988, 2:359-367.
18. Karamanos N.K., Manouras A., Politou D., Gritsoni P., Tsegenidis T. Isolation and high performance liquid chromatographic analysis of Ray (Raja clavata) skin glycosaminoglycans. Comp. Biochem. Physiol. B. 1991, 100:827-832.
19. Kyogashima M., Onaya J., Miyauchi S., Arai M., Shibata Y., Suda A., Sakai T., Takada Y., Takada A. Antithrombotic activity of avian crown dermatan sulfate. Thromb. Res. 1999, 96:459-465.
20. Liaw P.C.Y., Austin R.C., Fredenburgh J.C., Stafford A.R., Weitz J.I. Comparison of heparin and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II. J. Biol. Chem. 1999, 274:27,597-27,604.
21. Lindahl U., Thunberg L., Bäckström G., Riesenfeld J., Nordling K., Björk I. Extension and structural variability of the antithrombin binding sequence in heparin. J. Biol. Chem. 1984, 259:12,368-12,376.
22. Maaroufi R.M., Tapon-Bretaudière J., Mardiguian J., Sternberg C., Dautzenberg M.D., Fischer A.M. Influence of the oversulfation method and the degree of sulfation on the anticoagulant properties of dermatan sulfate derivatives. Thromb. Res. 1990, 59:749-758.
23. Maaroufi R.M., Jozefowicz M., Tapon-Bretaudière J., Jozefonvicz J., Fischer A.M. Mechanism of the inhibition of thrombin by heparin cofactor II in the presence of dermatan sulfates, native or oversulfated and a heparin-like dextran derivative. Biomaterials. 1997, 18:359-366.
24. Maaroufi R.M., Jozefowicz M., Tapon-Bretaudière J., Fischer A.M. Mechanism of thrombin inhibition by antithrombin III and heparin cofactor II in the presence of heparin. Biomaterials. 1997, 18:203-211.
25. Maaroufi R.M., Jozefonwicz M., Tapon-Bretaudière J., Fischer A.M. Thrombin inhibition by antithrombin in the presence of oversulfated dermatan sulfates. Carbohydr. Res. 2006, 341:672-676.
26. Maimone M.M., Tollefsen D.M. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J. Biol. Chem. 1990, 265:18,263-18,271.
27. Mitchell J.W., Church F.C. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition. J. Biol. Chem. 2002, 277:19,823-19,830.
28. Passos C.O., Werneck C.C., Onofre G.R., Pagani E.A., Filgueira A.L., Silva L.C.F. Comparative biochemistry of human skin: glycosaminoglycans from different body sites in normal subjects and in patients with localized scleroderma. J. Eur. Acad. Dermatol. 2003, 17:14-19.
29. Pavão M.S.G., Mourão P.A.S., Mulloy B., Tollefsen D.M. A unique dermatan sulfate-like glycosaminoglycans from ascidian. J. Biol. Chem. 1995, 270:31,027-31,036.
30. Pavão M.S.G., Aiello K.R., Werneck C.C., Silva L.C., Valente A.P., Mulloy B., Colwell N.S., Tollefsen D.M., Mourão P.A.S. Highly sulfated dermatan sulfates from ascidians. J. Biol. Chem. 1998, 273:27,848-27,857.
31. Saito N., Yamagata T., Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J. Biol. Chem. 1968, 243:1536-1544.
32. Sakai S., Kim W.S., Lee I.S., Kim Y.S., Nakamura A., Toida T., Imanari T. Purification and characterization of dermatan sulfate from the skin of the eel, Anguilla japonica. Carbohyd. Res. 2003, 338:263-269.
33. Santos J.C., Mesquita J.M.F., Belmiro C.L.R., da Silveira C.B.M., Viskov C., Mourier P.A., Pavão M.S.G. Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis. Thromb. Res. 2007, 121:213-223.
34. Sheehan J.P., Tollefsen D.M., Evan Sadler J. Heparin cofactor II is regulated allosterically and not primarily by template effects. J. Biol. Chem. 1994, 269:32,747-32,751.
35. Shively J.E., Conrad H.E. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochem. 1976, 15:3932-3942.
36. Souza M.L.S., Dellias J.M.M., Melo F.R., Silva L.C.F. Structural composition and anticoagulant activity of dermatan sulfate from the skin of the electric eel Electrophorus electricus (L.). Comp. Biochem. Physiol. B. 2007, 147:387-394.
37. Toida T., Maruyama T., Ogita Y., Suzuki A., Toyoda H., Imanari T., Linhardt R.J. Preparation and anticoagulant activity of fully O-sulphonated glycosaminoglycans. Int. J. Biol. Macromol. 1999, 26:233-241.
38. Tollefsen D.M., Pestka C.A., Monafo W.J. Activation of heparin cofactor II by dermatan sulfate. J. Biol. Chem. 1983, 258:6713-6716.
39. Tovar A.M.F., de Mattos D.A., Stelling M.P., Sarcinelli-Luz B.S.L., Nazareth R.A., Mourão P.A.S. Dermatan sulfate is predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II. Biochim. Biophys. Acta 2005, 1745:45-53.
40. Verhamme I.M., Bock P.E., Jackson C.M. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II. J. Biol. Chem. 2004, 279:9785-9795.
41. Vicente-Garcia V., Rios-Leal E., Calderon-Dominguez G., Canizares-Villanueva R.O., Olvera-Ramirez R. Detection, isolation and characterisation of exopolysaccharide produced by a strain of Phormidium 94a isolated from an arid zone in Mexico. Biotech. Bioeng. 2004, 85:306-310.
42. Volpi N., Maccari F., Titze J. Simultaneous detection of submicrogram quantities of hualuronic acid and dermatan sulfate on agarose-gel by sequential staining with toluidine blue and stains-all. J. Chromatogr. B. 2005, 820:131-135.
43. Wang S.C., Bligh S.W.A., Shi S.S., Wang Z.T., Hua Z.B., Crowder J., Branford-White C., Vella C. Structural features and anti-HIV-1 activity of novel polysaccharides from red algae Grateloupia longifolia and Grateloupia filicina. Int. J. Biol. Macromol. 2007, 41:369-375.
44. Warkentin T.E. HIT: lessons learned. Pathophysiol. Haemost. Thromb. 2006, 35(1-2):50-57.
45. Wegrowski Y., Maquart F.X. Cellulose acetate electrophoresis of glycosaminoglycans. Methods Mol. Biol. 2001, 171:175-179.
46. Yamagishi R., Koide T., Sakuragawa N. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II. FEBS. Letts. 1987, 225:109-112.